Characterisation and Prognostic Implication of Cholestasis After Burn Injury
Alimentary Pharmacology & Therapeutics · 2026
DOI: 10.1111/apt.70505 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2026. Verfasst von Lorenz Semmler und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Burns, Cholestasis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Cholestasis is a frequent phenomenon in patients with burn injury and linked with impaired outcomes.
Aims
To explore longitudinal trajectories of cholestasis and validate the proposed definition of burn‐associated cholestasis (BAC).
Methods
532 patients admitted to an intensive care unit (ICU) for burn injury over a 10‐year timeframe were included in this single‐center, retrospective cohort study. Burn severity, ICU treatment, and laboratory parameters were longitudinally collected from admission to discharge or death.
Results
Median total body surface area burned was 15% and 234 patients (44%) had severe burn (≥ 20%). 118 patients (22%) met the proposed criteria of BAC while 41%, 30%, and 68% developed elevated alkaline phosphatase, bilirubin, and gamma‐glutamyl transferase, respectively. BAC was associated with burn severity, ketamine use, mechanical ventilation, and parenteral nutrition, and 85% of cases occurred in patients exposed to ketamine, mechanical ventilation, and parenteral nutrition. Hyperbilirubinemia (≥ 2× upper‐limit‐of‐normal, i.e., BAC subtype B/C) was independently associated with mortality adjusting for burn severity, critical illness severity, and ICU‐specific treatment. However, bilirubin alone provided better discrimination, especially regarding excess deaths after ≥ 7 days (Harrel's C: 0.80–0.83). Concordant increases in bilirubin and alkaline phosphatase/gamma‐glutamyl transferase allow for early identification of an at‐risk population. Developing hyperbilirubinemia until Day 14 identified a subgroup with severely impaired prognosis (survival at 90 days: 46% vs. 95%).
Conclusions
Cholestasis is frequent following burn injury. Prognosis is determined by bilirubin dynamics independently of disease and burn severity. Hyperbilirubinemia is associated with excess mortality ≥ 7 days after surviving burn injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Vienna, Vienna, Austria.
- Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
- Department of Anesthesia, Critical Care and Pain Medicine, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Georg Semmler, Paul Supper
Zitieren
APA
Semmler, L., Semmler, G., Langa, A., Rihl, S., Hofstetter, S., Mateas, M. P., Dilmen, K., Borger, A., Supper, P., Haselwanter, P., Halilbasic, E., Zauner, C., Stättermayer, A., Ihra, G., Radtke, C., Schneeweiss-Gleixner, M. A., & Trauner, M. (2026). Characterisation and Prognostic Implication of Cholestasis After Burn Injury. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70505
Vancouver
Semmler L, Semmler G, Langa A, Rihl S, Hofstetter S, Mateas MP, et al. Characterisation and Prognostic Implication of Cholestasis After Burn Injury. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70505
BibTeX
@article{Semmler2026,
author = {Semmler, Lorenz and Semmler, Georg and Langa, Andreas and Rihl, Sebastian and Hofstetter, Sebastian and Mateas, Melissa-Patricia and Dilmen, Kevin and Borger, Anton and Supper, Paul and Haselwanter, Patrick and Halilbasic, Emina and Zauner, Christian and Stättermayer, Albert and Ihra, Gerald and Radtke, Christine and Schneeweiss-Gleixner, Mathias Anselm and Trauner, Michael},
title = {Characterisation and Prognostic Implication of Cholestasis After Burn Injury},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.70505}
}
EUVIMED